The new standard from the Clinical Data Interchange Standards Consortium (CDISC) will help industry generate submissions for multiple, global clinical trial registries, particularly those from the ...
We queried ClinicalTrials.gov to identify all completed or terminated phase III interventional studies investigating GECs (esophageal squamous cell carcinoma [ESCC], esophageal adenocarcinoma [EAC], ...
SYDNEY--(BUSINESS WIRE)--Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024 ...
SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the leading R&D procurement platform for the life sciences, today integrated Trial Insights™—its real‑time clinical‑trial analytics tool—into Clinical Labs ...
Perceptions of Value in Cancer Care Across Distinct Health Systems: A Comparison of Providers in High- and Low- and Middle-Income Countries Despite accounting for over 8% of the global population and ...
A phase 3 global trial is enrolling previously treated locally advanced/metastatic nonsquamous NSCLC to define DATROWAY efficacy and safety at scale. IDE034 is in open-label phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results